http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30910082

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 1826
issn 0270-9139
issueIdentifier 6
pageRange 1818-1826
publicationName Hepatology (Baltimore, Md.)
startingPage 1818
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc5a78a68f4eae114c74a1c9f7c0289f
bibliographicCitation Abdelmalek MF, Sanderson SO, Angulo P, Soldevila-Pico C, Liu C, Peter J, Keach J, Cave M, Chen T, McClain CJ, Lindor KD. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology. 2009 Dec;50(6):1818–26. doi: 10.1002/hep.23239. PMID: 19824078.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a12b79349d8067876475a2e4c2cf3f10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f240c43f03981ef6339c02347a80ce51
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27a0f84bb14f5a8332feb4f28fc208ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4740579f591935ca37878f738bee267d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44f181c57d91af37187102e3228a2a7d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa032c9df6363d732ddf4d616eebd405
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c65848ce1081277821f59ac3554fe70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4050496120481d2003bdb5e4ba5bee8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22db86abd861b61e56d26c5d51cf4866
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5edd9bbe99b2a60798cc617804d0d15e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33045c00398bda1fbe4ae43716fa1ab0
date 2009-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19824078
https://doi.org/10.1002/hep.23239
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4093
https://portal.issn.org/resource/ISSN/0270-9139
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
discusses http://id.nlm.nih.gov/mesh/M0024747
http://id.nlm.nih.gov/mesh/M0019321
http://id.nlm.nih.gov/mesh/M0504569
http://id.nlm.nih.gov/mesh/M0002435
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D005234Q000188
http://id.nlm.nih.gov/mesh/D001622Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D054392Q000097
http://id.nlm.nih.gov/mesh/D005234Q000378
http://id.nlm.nih.gov/mesh/D001622Q000009
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D016207Q000097
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D012435Q000097
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91552
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_67be0b057f2811fe207568ef01325eda
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439155
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129912970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128444182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 61.